USD10
FDMT Shares
About 4D Molecular Therapeutics4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.
USD10
FDMT Shares
About 4D Molecular Therapeutics4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.
Stats
TRADING WINDOW
Closed
OPENS AT
Not enough data
MARKET CAP
$439.18M
OPEN PRICE
$8.63
LOW (1Y)
$2.24
HIGH (1Y)
$12.34
LOW (24H)
$8.59
HIGH (24H)
$9.10
VOLUME (24H)
$1.37M
87.67%
Price history
Time | Price | Change |
|---|---|---|
Today | $8.63 | |
1 Day | $8.61 | 0.00% |
1 Week | $8.65 | |
1 Month | $8.80 | |
1 Year | $3.93 |